Long‐term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3303
Abstract: The long‐term impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on renal functions remains undefined. This study was undertaken to investigate the renal outcomes associated with SGLT2 inhibitors in patients with type 2 diabetes (T2DM)… read more here.
Keywords: term; sodium glucose; long term; outcomes associated ... See more keywords
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
Sign Up to like & getrecommendations! Published in 2021 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13236
Abstract: The CANVAS Program identified the effect of canagliflozin on major adverse cardiovascular events (MACE) differed according to whether participants were using diuretics at study commencement. We sought to further evaluate this finding related to baseline… read more here.
Keywords: canvas program; renal outcomes; canvas; cardiovascular renal ... See more keywords
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2707
Abstract: Empagliflozin improves cardiovascular and renal outcomes in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but its efficacy and safety across patient's age is not well established. read more here.
Keywords: heart failure; failure reduced; renal outcomes; heart ... See more keywords
Subclinical hypothyroidism is independently associated with poor renal outcomes in patients with chronic kidney disease
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine"
DOI: 10.1007/s12020-021-02611-6
Abstract: It remains unclear whether subclinical hypothyroidism (SCH) is associated with renal prognosis in patients with chronic kidney disease (CKD). Therefore, we prospectively investigated the association of SCH with renal outcomes in CKD. We conducted a… read more here.
Keywords: associated poor; scr esrd; disease; renal outcomes ... See more keywords
Cardio-renal outcomes and the direct medical cost of type 2 diabetes patients treated with sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based cohort study.
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2021.109071
Abstract: AIMS To compare cardio-renal outcomes and incurred direct medical costs of patients initiating sodium glucose cotransporter-2 inhibitors (SGLT2i) versus glucagon-like peptide-1 receptor agonists (GLP-1RA). METHODS A population-based cohort of patients with type 2 diabetes was… read more here.
Keywords: glp 1ra; sodium glucose; cardio renal; direct medical ... See more keywords
Renal Outcomes and the Relative Benefit and Harm of Intensive Treatment of Hypertension.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.04.090
Abstract: We read with interest the paper by Philips et al. [(1)][1] reporting the effect of baseline 10-year cardiovascular disease risk on primary outcome events and all-cause serious adverse events in SPRINT (Systolic Blood Pressure Intervention Trial).… read more here.
Keywords: benefit harm; renal outcomes; intensive treatment; outcomes relative ... See more keywords
Allopurinol and Renal Outcomes in Adults With and Without Type 2 Diabetes: A Retrospective, Population-Based Cohort Study and Propensity Score Analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Canadian journal of diabetes"
DOI: 10.1016/j.jcjd.2021.01.005
Abstract: OBJECTIVES Elevated uric acid (UA) is common in diabetes and is implicated in the pathogenesis of chronic kidney disease (CKD). Lowering UA with allopurinol may delay CKD progression. We assessed the association between allopurinol and… read more here.
Keywords: population based; adults without; renal outcomes; older adults ... See more keywords
Association of gender, age, and race on renal outcomes and mortality in patients with severe sepsis and septic shock.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of critical care"
DOI: 10.1016/j.jcrc.2020.10.007
Abstract: BACKGROUND The association of age, gender and race with renal outcomes in patients with severe sepsis and septic shock (SEP) is not completely elucidated. We aimed to shed light on these relationships. METHODS We performed… read more here.
Keywords: race renal; risk; age; gender ... See more keywords
Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of diabetes and its complications"
DOI: 10.1016/j.jdiacomp.2016.10.024
Abstract: AIMS To investigate the renal pathological implications in type 2 diabetes mellitus patients with renal involvement. METHODS A total of 328 type 2 diabetes mellitus (T2DM) patients with renal involvement who underwent a renal biopsy… read more here.
Keywords: patients renal; renal outcomes; renal involvement; diabetes mellitus ... See more keywords
Impact of Intentional Accessory Renal Artery Coverage on Renal Outcomes after Fenestrated-Branched Endovascular Aortic Repair.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of vascular surgery"
DOI: 10.1016/j.jvs.2020.06.123
Abstract: PURPOSE To evaluate the impact of intentional coverage of accessory renal arteries (ARA) on renal outcomes after fenestrated-branched endovascular aortic repair (FB-EVAR) for pararenal aortic aneurysms or thoracoabdominal aortic aneurysm. METHODS We analyzed the clinical… read more here.
Keywords: impact intentional; renal outcomes; accessory renal; coverage ... See more keywords
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Sign Up to like & getrecommendations! Published in 2019 at "The Lancet"
DOI: 10.1016/s0140-6736(19)31150-x
Abstract: BACKGROUND Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the long-term effect of the GLP-1 receptor agonist dulaglutide on renal outcomes… read more here.
Keywords: placebo; type diabetes; renal outcomes; trial ... See more keywords